Henriette Lindberg

1.7k total citations
40 papers, 599 citations indexed

About

Henriette Lindberg is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Henriette Lindberg has authored 40 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 17 papers in Surgery and 12 papers in Oncology. Recurrent topics in Henriette Lindberg's work include Prostate Cancer Treatment and Research (17 papers), Bladder and Urothelial Cancer Treatments (16 papers) and Advanced Radiotherapy Techniques (9 papers). Henriette Lindberg is often cited by papers focused on Prostate Cancer Treatment and Research (17 papers), Bladder and Urothelial Cancer Treatments (16 papers) and Advanced Radiotherapy Techniques (9 papers). Henriette Lindberg collaborates with scholars based in Denmark, United States and Sweden. Henriette Lindberg's co-authors include Helle Pappot, Gry Assam Taarnhøj, Christoffer Johansen, Benny Vittrup Jensen, Inge Marie Svane, Lisa Sengeløv, Torben Skovsgaard, Per Kongsted, Dorte Nielsen and Jens Ole Eriksen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Journal of Urology.

In The Last Decade

Henriette Lindberg

38 papers receiving 589 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Henriette Lindberg Denmark	14	268	169	167	145	122	40	599
Lukas Käsmann Germany	17	510 1.9×	71 0.4×	483 2.9×	151 1.0×	221 1.8×	99	977
Christopher Pieczonka United States	12	433 1.6×	63 0.4×	136 0.8×	142 1.0×	111 0.9×	69	679
Mark Farrugia United States	15	277 1.0×	47 0.3×	172 1.0×	161 1.1×	88 0.7×	69	745
Rangesh Kunnavakkam United States	17	420 1.6×	29 0.2×	249 1.5×	209 1.4×	56 0.5×	29	800
Sara Falivene Italy	9	137 0.5×	60 0.4×	315 1.9×	70 0.5×	105 0.9×	27	521
Hsing‐Lung Chao Taiwan	17	283 1.1×	142 0.8×	200 1.2×	291 2.0×	106 0.9×	36	764
Tommy Sheu United States	10	194 0.7×	58 0.3×	134 0.8×	64 0.4×	75 0.6×	23	418
Göran Ahlgren Sweden	18	943 3.5×	37 0.2×	170 1.0×	194 1.3×	138 1.1×	45	1.2k
Sara Kinhult Sweden	11	400 1.5×	29 0.2×	423 2.5×	51 0.4×	118 1.0×	28	809
Ezra Hahn Canada	12	183 0.7×	42 0.2×	96 0.6×	111 0.8×	78 0.6×	48	450

Countries citing papers authored by Henriette Lindberg

Since Specialization

Citations

This map shows the geographic impact of Henriette Lindberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henriette Lindberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henriette Lindberg more than expected).

Fields of papers citing papers by Henriette Lindberg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Henriette Lindberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henriette Lindberg. The network helps show where Henriette Lindberg may publish in the future.

Co-authorship network of co-authors of Henriette Lindberg

This figure shows the co-authorship network connecting the top 25 collaborators of Henriette Lindberg. A scholar is included among the top collaborators of Henriette Lindberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Henriette Lindberg. Henriette Lindberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bryce, Alan H., Ray McDermott, Josep M. Piulats, et al.. (2025). Rucaparib vs docetaxel (DTX) or second-generation androgen pathway inhibitor (ARPI) therapy for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 final overall survival (OS) and safety.. Journal of Clinical Oncology. 43(5_suppl). 155–155. 3 indexed citations

Persson, Gitte Fredberg, Susann Theile, Dorte Nielsen, et al.. (2023). Randomised phase II trial of stereotactic body radiotherapy in combination withcheckpoint inhibitors in metastatic castration-resistantprostate cancer (CheckPRO): a study protocol. BMJ Open. 13(1). e063500–e063500. 2 indexed citations

Taarnhøj, Gry Assam, Christoffer Johansen, Andreas Carus, et al.. (2023). The iBLAD study: patient-reported outcomes in bladder cancer during oncological treatment: a multicenter national randomized controlled trial. Journal of Patient-Reported Outcomes. 7(1). 99–99. 3 indexed citations

Stranne, Johan, Eva Johansson, Matteo Bottai, et al.. (2022). Characteristics of Patients in SPCG-15—A Randomized Trial Comparing Radical Prostatectomy with Primary Radiotherapy plus Androgen Deprivation Therapy in Men with Locally Advanced Prostate Cancer. European Urology Open Science. 41. 63–73. 7 indexed citations

Behrens, C.F., L. Calmels, C. David Sjöström, et al.. (2022). Online adaptive radiotherapy of urinary bladder cancer with full re-optimization to the anatomy of the day: Initial experience and dosimetric benefits. Radiotherapy and Oncology. 171. 37–42. 55 indexed citations

Ammitzbøll, Gunn, Cecilia Margareta Lund, Henriette Lindberg, et al.. (2022). Muscle mass and physical function in patients with bladder cancer—Data from a prematurely terminated prospective cohort study. SHILAP Revista de lepidopterología. 3. 942475–942475. 1 indexed citations

Calmels, L., Patrik Sibolt, Eva Serup‐Hansen, et al.. (2022). Evaluation of an automated template-based treatment planning system for radiotherapy of anal, rectal and prostate cancer. Technical Innovations & Patient Support in Radiation Oncology. 22. 30–36. 21 indexed citations

Als, Anne Birgitte, Mads Agerbæk, Henriette Lindberg, et al.. (2021). Implications for Efficacy and Safety of Total Dose and Dose-Intensity of Neoadjuvant Gemcitabine-Cisplatin in Muscle-Invasive Bladder Cancer: Three-Week Versus Four-Week Regimen. Bladder Cancer. 8(1). 71–80. 4 indexed citations

Lendorf, Maria Elisabeth, et al.. (2021). Effectiveness of Docetaxel for Metastatic Hormone-sensitive Prostate Cancer in Clinical Practice. European Urology Open Science. 24. 25–33. 8 indexed citations

10.

Lindberg, Henriette, Andreas Carus, Anne Birgitte Als, et al.. (2020). Real-world Treatment Patterns and Overall Survival in Locally Advanced and Metastatic Urothelial Tract Cancer Patients Treated with Chemotherapy in Denmark in the Preimmunotherapy Era: A Nationwide, Population-based Study. European Urology Open Science. 24. 1–8. 20 indexed citations

11.

Sibolt, Patrik, Lina Andersson, L. Calmels, et al.. (2020). Results of a Pilot Study on Online Adaptive Radiotherapy of Bladder Cancer with Artificial Intelligence-driven Full Re-optimization on the Anatomy of the Day. International Journal of Radiation Oncology*Biology*Physics. 108(3). S79–S80. 5 indexed citations

12.

Taarnhøj, Gry Assam, Christoffer Johansen, Henriette Lindberg, et al.. (2020). Patient reported symptoms associated with quality of life during chemo‐ or immunotherapy for bladder cancer patients with advanced disease. Cancer Medicine. 9(9). 3078–3087. 24 indexed citations

13.

Taarnhøj, Gry Assam, et al.. (2020). Electronic reporting of patient-reported outcomes in a fragile and comorbid population during cancer therapy – a feasibility study. Health and Quality of Life Outcomes. 18(1). 225–225. 23 indexed citations

14.

Taarnhøj, Gry Assam, Henriette Lindberg, Christoffer Johansen, & Helle Pappot. (2019). Patient-reported outcomes item selection for bladder cancer patients in chemo- or immunotherapy. Journal of Patient-Reported Outcomes. 3(1). 56–56. 17 indexed citations

15.

Østergren, Peter Busch, Christian Fuglesang S. Jensen, Henrik Jakobsen, et al.. (2019). Hormone naïve metastatic prostate cancer: How to treat it?. PubMed. 72(2). 192–202. 1 indexed citations

16.

Frey, Anders, et al.. (2017). Prevalence and Predicting Factors for Commonly Neglected Sexual Side Effects to External-Beam Radiation Therapy for Prostate Cancer. The Journal of Sexual Medicine. 14(4). 558–565. 33 indexed citations

17.

Kongsted, Per, Troels Holz Borch, Eva Ellebæk, et al.. (2017). Dendritic cell vaccination in combination with docetaxel for patients with metastatic castration-resistant prostate cancer: A randomized phase II study. Cytotherapy. 19(4). 500–513. 69 indexed citations

18.

Vestergaard, Anne, L.P. Muren, Henriette Lindberg, et al.. (2015). OC-0107: Normal tissue sparing in a Phase II trial of daily adaptive plan selection in radiotherapy for urinary bladder cancer. Radiotherapy and Oncology. 115. S51–S52. 1 indexed citations

19.

Vestergaard, Anne, L.P. Muren, Henriette Lindberg, et al.. (2014). Normal tissue sparing in a phase II trial on daily adaptive plan selection in radiotherapy for urinary bladder cancer. Acta Oncologica. 53(8). 997–1004. 56 indexed citations

20.

Hansen, Rasmus Hvass, et al.. (2012). PO-0863 PRECISION OF NITINOL PROSTATE FIDUCIAL MARKER DEFINITION ON T2 MRI IN CLINICAL PRACTICE. Radiotherapy and Oncology. 103. S337–S338. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact